DNA
The hardware I was issued. Fixed. Read through IntellxxDNA as clinical decision support, not as a diagnosis.
DNA is the starting kit. SPECT and QEEG looked later. I am not resolving the places they disagree.
The hardware I was issued. Fixed. Read through IntellxxDNA as clinical decision support, not as a diagnosis.
Electrical rhythm against an age-matched map. It moved across six weeks on the Peak Brain page.
Blood flow and activity. What is working, working too hard, or running low. That page stays the Amen view.
I went looking because of concussions. The two machines looked at what my brain is doing now. The genomic panel is older than both of those stories. I am not inventing appointment dates that the source pages do not print.
Until that exists, the safe default is to refuse invented agreement. A low-drive frontal signature on QEEG is not the same construct as a receptor row on this panel.
Caffeine is called out as a problem and coffee is recommended for amyloid suppression. Stimulant-response direction conflicts across rows. Those fights stay visible on the spokes that own them.
SPECT and QEEG do not directly measure genetic amyloid-clearance mechanisms. I will not pretend a pretty map confirms a letter change.
How it works is the primer. The library is the index. The other spokes are the payload.
Same brain. Two more instruments. I am not collapsing them into this panel.